Department of Psychosis Studies, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, UK.
Department of Neuroimaging, School of Neuroscience, Institute of Psychiatry, Psychology, and Neuroscience, King's College London, London, UK.
Schizophr Bull. 2023 May 3;49(3):569-580. doi: 10.1093/schbul/sbac192.
Converging lines of evidence suggest that dysfunction of cortical GABAergic inhibitory interneurons is a core feature of psychosis. This dysfunction is thought to underlie neuroimaging abnormalities commonly found in patients with psychosis, particularly in the hippocampus. These include increases in resting cerebral blood flow (CBF) and glutamatergic metabolite levels, and decreases in ligand binding to GABAA α5 receptors and to the synaptic density marker synaptic vesicle glycoprotein 2A (SV2A). However, direct links between inhibitory interneuron dysfunction and these neuroimaging readouts are yet to be established. Conditional deletion of a schizophrenia susceptibility gene, the tyrosine kinase receptor Erbb4, from cortical and hippocampal inhibitory interneurons leads to synaptic defects, and behavioral and cognitive phenotypes relevant to psychosis in mice.
Here, we investigated how this inhibitory interneuron disruption affects hippocampal in vivo neuroimaging readouts. Adult Erbb4 conditional mutant mice (Lhx6-Cre;Erbb4F/F, n = 12) and their wild-type littermates (Erbb4F/F, n = 12) were scanned in a 9.4T magnetic resonance scanner to quantify CBF and glutamatergic metabolite levels (glutamine, glutamate, GABA). Subsequently, we assessed GABAA receptors and SV2A density using quantitative autoradiography.
Erbb4 mutant mice showed significantly elevated ventral hippccampus CBF and glutamine levels, and decreased SV2A density across hippocampus sub-regions compared to wild-type littermates. No significant GABAA receptor density differences were identified.
These findings demonstrate that specific disruption of cortical inhibitory interneurons in mice recapitulate some of the key neuroimaging findings in patients with psychosis, and link inhibitory interneuron deficits to non-invasive measures of brain function and neurochemistry that can be used across species.
越来越多的证据表明,皮质 GABA 能抑制性中间神经元功能障碍是精神分裂症的核心特征。这种功能障碍被认为是精神分裂症患者常见的神经影像学异常的基础,特别是在海马体中。这些异常包括静息脑血流(CBF)和谷氨酸代谢物水平增加,以及 GABAAα5 受体和突触密度标记物突触小泡糖蛋白 2A(SV2A)配体结合减少。然而,抑制性中间神经元功能障碍与这些神经影像学指标之间的直接联系尚未建立。条件性敲除酪氨酸激酶受体 Erbb4 可导致皮质和海马抑制性中间神经元的突触缺陷,并导致小鼠出现与精神分裂症相关的行为和认知表型。
在这里,我们研究了这种抑制性中间神经元破坏如何影响海马体的体内神经影像学指标。成年 Erbb4 条件性突变小鼠(Lhx6-Cre;Erbb4F/F,n=12)及其野生型同窝仔鼠(Erbb4F/F,n=12)在 9.4T 磁共振扫描仪中进行扫描,以定量 CBF 和谷氨酸代谢物水平(谷氨酰胺、谷氨酸、GABA)。随后,我们使用定量放射自显影术评估 GABAA 受体和 SV2A 密度。
与野生型同窝仔鼠相比,Erbb4 突变小鼠的海马体腹侧 CBF 和谷氨酰胺水平显著升高,海马体各区域的 SV2A 密度降低。未发现 GABAA 受体密度差异。
这些发现表明,在小鼠中特异性破坏皮质抑制性中间神经元可重现精神分裂症患者的一些关键神经影像学发现,并将抑制性中间神经元缺陷与可用于跨物种的非侵入性脑功能和神经化学测量联系起来。